3-3148094-GA-GAA
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1_ModeratePP5_Very_Strong
The NM_182916.3(TRNT1):c.1252dupA(p.Ser418LysfsTer9) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000241 in 1,613,242 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_182916.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- intellectual disabilityInheritance: AR Classification: MODERATE Submitted by: ClinGen
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual disability, autosomal recessive 2Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TRNT1 | NM_182916.3 | c.1252dupA | p.Ser418LysfsTer9 | frameshift_variant | Exon 8 of 8 | ENST00000251607.11 | NP_886552.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 151934Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000275 AC: 69AN: 250732 AF XY: 0.000295 show subpopulations
GnomAD4 exome AF: 0.000248 AC: 363AN: 1461308Hom.: 0 Cov.: 32 AF XY: 0.000263 AC XY: 191AN XY: 726968 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000171 AC: 26AN: 151934Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74184 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation, as the last 17 amino acids are replaced with 8 different amino acids, and other similar variants have been reported in HGMD; This variant is associated with the following publications: (PMID: 26494905, 29358286, 25193871, Jung2023[Abstract]) -
- -
Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ser418Lysfs*9) in the TRNT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 17 amino acid(s) of the TRNT1 protein. This variant is present in population databases (rs758671550, gnomAD 0.05%). This premature translational stop signal has been observed in individuals with TRNT1-related conditions (PMID: 25193871, 26494905, 29358286; internal data). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1246A[8]. ClinVar contains an entry for this variant (Variation ID: 234934). For these reasons, this variant has been classified as Pathogenic. -
- -
Retinitis pigmentosa and erythrocytic microcytosis Pathogenic:1
- -
TRNT1-related disorder Pathogenic:1
Variant summary: TRNT1 c.1252dupA (p.Ser418LysfsX9) located in the last exon results in a premature termination codon, predicted to cause a truncation of the encoded protein and expected to disrupt the last 17 amino acid(s) of the TRNT1 protein. The variant allele was found at a frequency of 0.00028 in 250732 control chromosomes. This frequency des not allow conclusions about variant significance. c.1252dupA has been reported in the literature in individuals affected with TRNT1-Related Disorders, as a biallelic compound heterozygous genotype in at-least two individuals with features of congenital sideroblastic anaemia with immunodeficiency, fevers and developmental delay (SIFD) and as a different variant (1246delA, p.S418fs) resulting in a frameshift at Ser418 in three individuals with molecularly uncharacterized RP (example, Chakraborty_2014, DeLuca_2016, Giannelou_2018). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at